A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects.More than ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid medications, according to a new ...

Nektar Therapeutics (NKTR) showcases financial resilience and advances in its ResPEG program, despite facing market challenges and uncertainties.

Just a third of health staff had the flu jab last year, leading to fears that vulnerable patients will catch the virus in ...

A large clinical trial published in The Lancet Respiratory Medicine has found that a monthly injection of tezepelumab may ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

This Comment is an urgent global call to action. I, as a pulmonologist, have concerns regarding the impacts of environmental ...

Enanta Pharmaceuticals, Inc.'s strong pipeline, positive RSV drug data, and solid cash position drive growth. Click for my ...

Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data cutoff:31 (97%) were ...

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...

Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in 1H26 – – New Drug Application for rademikibart for ...

Minnow Inhalerx hopes to be first to market with inhaled synthetic medical cannabis therapies for cancer pain and panic ...